Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lumiquick Diagnostics is a healthcare diagnostics company focused on in vitro diagnostic products and rapid point-of-care testing. The company appears to market commercial diagnostic assays and related test products rather than developing a therapeutic drug pipeline. Its product focus is associated with rapid tests in areas such as infectious diseases, respiratory illnesses, pregnancy and fertility, and drugs-of-abuse screening. Based on the available public footprint, Lumiquick operates as a commercial diagnostics supplier rather than a therapeutics biotech company. Publicly available evidence for clinical-stage drug programs, molecular targets, or therapeutic assets was not identified.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lumiquick Diagnostics.